Stockscreener 앱 받기
48.35
0.39%
-0.19
시장 영업 전:
47.30
-1.05
-2.17%
Atricure Inc 주식(ATRC)의 최신 뉴스
A Look at AtriCure Inc (ATRC) After 3.0% Gain -- GF Value $39.53 vs Price $48.98 - GuruFocus
AtriCure stock hits 52-week high at 48.47 USD - Investing.com
AtriCure stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Canada
AtriCure Stock: Promising Cardiovascular Surgical Platform (NASDAQ:ATRC) - Seeking Alpha
Advisors Capital Management LLC Takes Position in AtriCure, Inc. $ATRC - MarketBeat
Bank of America Corp DE Buys 92,830 Shares of AtriCure, Inc. $ATRC - MarketBeat
134,207 Shares in AtriCure, Inc. $ATRC Acquired by Rice Hall James & Associates LLC - MarketBeat
AtriCure (NASDAQ:ATRC) Hits New 52-Week HighTime to Buy? - MarketBeat
Assenagon Asset Management S.A. Buys New Position in AtriCure, Inc. $ATRC - MarketBeat
AllianceBernstein L.P. (ATRC) reports 5.5% beneficial ownership in AtriCure - Stock Titan
AtriCure Inc. (ATRC) Holds Steady at $43.59 as Range-Bound Trading PersistsTrading Ideas - vinanet.vn
AtriCure stock hits 52-week high at $43.19 By Investing.com - Investing.com Australia
AtriCure stock hits 52-week high at $43.19 - Investing.com
More than 500,000 hours of development, innovation, testing, and refinement across three generations have shaped the AtriClip portfolio into what it is today. - t.co
AtriCure, Inc.Common Stock (ATRC) Stock Price, News, Quote & History - FinancialContent
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth - Yahoo Finance
A Look at AtriCure Inc (ATRC) After 3.1% Gain -- GF Value $39.42 vs Price $42.95 - GuruFocus
AtriCure (NASDAQ:ATRC) Sets New 12-Month HighHere's Why - MarketBeat
ATRC: Strong growth, innovation, and clinical trial catalysts drive robust financial and market expansion - TradingView
Discipline and Rules-Based Execution in ATRC Response - Stock Traders Daily
AtriCure director Karen Prange sells $138,283 in stock By Investing.com - Investing.com UK
AtriCure director Maggie Yuen sells $134,470 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Stock News Today - TradingKey
Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors - fool.com
An AtriCure Director Sold $905,000 in Stock. Here's How to Read It - fool.com
AtriCure Inc (ATRC) Director Karen Prange Sells 3,564 Shares - GuruFocus
AtriCure (NASDAQ:ATRC) Director Sells 3,500 Shares - marketbeat.com
AtriCure (NASDAQ:ATRC) Director Sells $138,283.20 in Stock - marketbeat.com
AtriCure director Maggie Yuen sells $134,470 in stock - Investing.com
Director At AtriCure Sells $134K Of Stock - Benzinga
AtriCure director Karen Prange sells $138,283 in stock - Investing.com
AtriCure, Inc. (ATRC) director sells 3,564 shares at $38.80 - Stock Titan
AtriCure (ATRC) director Maggie Yuen reports sale of 3,500 shares - Stock Titan
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AtriCure director Maggie Yuen sells 3,500 shares worth $134,470 - Bitget
AtriCure (ATRC) Holds Near $39.49 as Resistance at $41.46 Caps Near-Term UpsideTrend Continuation Trade - vinanet.vn
AtriCure, Inc. SEC Filing (Aug 5, 2026) - stocktitan.net
AtriCure (ATRC) insider plans NASDAQ sale of 3,564 awarded shares - Stock Titan
We Think AtriCure's (NASDAQ:ATRC) Profit Is Only A Baseline For What They Can Achieve - Moomoo
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 22.25% Upside in the Healthcare Sector - DirectorsTalk Interviews
AtriCure, Inc. $ATRC Stock Position Raised by First Trust Advisors LP - MarketBeat
Will AtriCure’s (ATRC) Profit Turn and ESOP Share Plans Recast Its Investment Narrative? - simplywall.st
Form 4 AtriCure Inc For: 3 August By Investing.com - Investing.com Nigeria
AtriCure, Inc. (ATRC) CEO makes 4,700-share stock gifts to family, charity - Stock Titan
Sei Investments Co. Has $7.44 Million Position in AtriCure, Inc. $ATRC - MarketBeat
Arrowstreet Capital Limited Partnership Takes Position in AtriCure, Inc. $ATRC - MarketBeat
A Look at AtriCure Inc (ATRC) After 6.0% Decline -- GF Value $39 - GuruFocus
Board Member At AtriCure Exercises Options Worth $491K - benzinga.com
Insider Selling: Vinayak Doraiswamy Unloads $233K Of AtriCure Stock - Benzinga
AtriCure (ATRC) Insider Sale: Chief Mktg & Strategy Officer Just - GuruFocus
ATRCRevenue by Segment - quiverquant.com
AtriCure (NASDAQ: ATRC) director exercises 25,000 options and sells 25,000 shares - Stock Titan
AtriCure (NASDAQ:ATRC) Upgraded at UBS Group - MarketBeat
Form 144 AtriCure For: 29 July By Investing.com - Investing.com Nigeria
AtriCure Surges After Q2 Earnings Beat: Key Drivers for Future GrowthDividend Earnings Report - vinanet.vn
Behavioral Patterns of ATRC and Institutional Flows - Stock Traders Daily
AtriCure Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Inspire Medical Systems appoints Michael H. Carrel to its board - Medical Buyer
AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here’s What Could Drive ATRC Stock Next - Yahoo Finance
AtriCure (ATRC) investor plans to sell 6,000 shares in Rule 144 filing - Stock Titan
ATRC SWOT Analysis: Strong Revenue Growth and Innovation Highlig - GuruFocus
AtriCure, Inc. (ATRC) Q2 2026 10-Q Report: Financial Performance, Earnings, and Stockholder Updates - Minichart
AtriCure CEO Carrel joins Inspire Medical board of directors - MassDevice
AtriCure, Inc. 2026: Revenue $153.6M, EPS $0.18— 10-Q Summary - TradingView
1.40%
0.50%
자본화:
|
볼륨(24시간):